What sector does Kukje Pharma Co., Ltd. belong to?

Kukje Pharma Co., Ltd. operates in the Pharmaceuticals sector, specifically the Pharmaceuticals industry, and is listed on the US markets.

What is the current share price of 002720?

As of the latest available quote, 002720 traded at ₩3,305.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 002720?

Kukje Pharma Co., Ltd. has a price-to-earnings (P/E) ratio of about 11.80. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 002720?

The market capitalisation of Kukje Pharma Co., Ltd. is approximately ₩67.34B.

Is Kukje Pharma Co., Ltd. profitable?

For its latest reported financial year, Kukje Pharma Co., Ltd. recorded a net profit margin of about 3.25%.

Does 002720 pay a dividend?

Kukje Pharma Co., Ltd. currently has a dividend yield of about 0.64%.

What is the return on equity (ROE) of 002720?

Kukje Pharma Co., Ltd. has a return on equity (ROE) of about 5.83%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 002720?

Over the past 52 weeks, 002720 has traded between a low of ₩2,810.00 and a high of ₩5,470.00.

Kukje Pharma Co., Ltd.

002720 KRX Pharmaceuticals Pharmaceuticals

KOSPI

₩3,305.00

-0.60%

Delayed · cached 15 min

Fair value analysis

002720

Kukje Pharma Co., Ltd.

₩3,305.00

Close used for this calculation

₩3,497.19Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

40/100

Profitability4/25

Returns8/25

Balance Sheet12/25

Efficiency16/25

Growth2/25

Average

Quality radar

Consensus fair value

₩3,497.19

Near FV

▲ +5.8% against the close used

Model range ₩1,855.78 – ₩5,600.00

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩1,855.78Fair value₩3,497.19Bull₩5,600.00

FairClose

52-week traded range

52W low ₩3,045.0052W high ₩5,230.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

Kukje Pharma Co., Ltd. closed at ₩3,305.00, 5.5% below the consensus fair value of ₩3,497.19 drawn from 7 valuation models.

Financial DNA score 40/100 — Average. P/E of 11.8x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₩2,038.79

-38.3%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₩5,377.62

+62.7%

√(22.5 × EPS × BVPS)

EPS=280, BVPS=4590.28

P/E Fair Value

₩5,600.00

+69.4%

EPS × 20x (sector P/E)

EPS=280, Sector P/E=20x

EV/EBITDA

₩2,888.33

-12.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=6.18B

Book Value (P/B)

₩1,855.78

-43.8%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=4590.28, ROE=5.8%, g=3%, r=10%

Reverse DCF

₩3,305.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: -0% | Historical: 0%

Margin of Safety

₩3,254.10

-1.5%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=4338.8, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer